A nonin vasive external nasal dilator device was used by 20 subj ects with a history of mild snoring in a 2 week open label study. The baseline assessments were obtained during the first week. Treatment effects were evaluated during the second week. Subjects were evaluated using: pre-lind post-sleep questionnaires; Stanfo rd Sleepin ess Scales completed at breakfast, lunch and dinner ;and postsleep bed partner questionnnaires. All twenty subje cts completed the study. A significant numb er of subj ects' scores improved for sleepiness. Mean scores for the subj ective assessment for ease of breathin g during sleep impro ved compared to baselin e by 25.6%, snoring loudness improved by 34%, sleep quality impro ved by 2/.8%, and the Stanford Sleepiness Scale revealed a 26% reduction in daytime sleepiness.
Introduction
Obstructive Sleep Apnea is a condition whose prevalence increases across age groups and may be present in more than 50%of males above age 60. 1 It isassociated with loud snoring and may be the end result of a gradual worsening of the conditions that contribute to snoring." Snoring reflects loose tissue vibrating in the upper airway and nasal obstructions. Many patients note that snoring worsens when they suffer from an upper airway infection or nasal inflammatory process and many indicate that nasal airflow is compromised when they liedown." Nasal airway resistance, which increases with structural or mucosal nasal airway disease, is often greater during sleep than wakefulness. As such, patients may have no difficulties when awake but have significant problems while asleep. ' Mechanical appliances have been used to enhance the flow of air through the nose for deviated septum and allergic rhinitis, nasal polyps, alar and valve insufficiency, post nasal drip, sinus headache and the common cold. Mechanical nasal dilators inserted in the nose have been used to increase airway patency.' The development of a noninvasive external nasal dilator device is an advance that may have a significant impact on snoring and the treatment of mild obstructive sleep apnea.
"Breathe Right®" (CNS, Inc., Chanhassen, MN) is a non-invasive external nasal dilator designed to slightly dilate the nares at the anterior aspect of the nasal valve. The nasal dilator comprises a truss member having the first end adapted to engage the outer wall tissue of the first nasal passage. A second end of the truss member is configured to engage the outer wall tissue of the second nasal passage. The first and second ends of the truss memb er are coupled to one another by an intermediate segment. The intermediate segment is con figur ed to traverse a portion ofthe nose located between the first and seco nd nasal passages ( Figure  I) . The truss member, when in place, acts to stabilize the outer wall tissue and thereby prevent the outer wall tissue of the nasal passages from collapsing during inspiration. A greater initial diamet er decreases the dyn amic air flow resistance associated with upper airway respiratory disturbance. The purpose of this study was to subjectively evaluate the effect s of the Breathe Right ® dev ice on snoring intensity and sleep quality through the use of patient and bed partn er questionnaires.
Table 1. Stanford Sleepiness Scale
Circle the ONE number that best describes your level of ___ _ _a :::.:l -=. e: . . . . : r t .:..:.ne ;::..s ::.:s =--o .::.:.r sleepiness rig. : . . : . ht-=--n :..:.o =--w : . . : . . : . . . -. _ 1. Feeling active, vital, alert, wide awake.
2. Functioning at a high level but not at peak, able to concentrate. 3. Relaxed, awake, but not fully alert, responsive . 4. A little foggy, let down. 5. Foggy, beginning to lose track, difficulty in staying awake. 6. Sleep, prefer to lie down, woozy. 7. Almost in reverie, cannot stay awake, sleep onset appears imminent.
'Age is at time of en try into the study . 2Heighl is in inches and weig ht is in pounds. ' Size was determined from a measure of the bridge of the nose from left to right of the fucial plute in centimet ers .
consistent bed time throughout the study. However, the subjects were instructed to go to bed early if they were tired and asked not to sleep late. Unusual exercise or act ivities were to be avoided and the subjec ts were asked to report any extreme changes in daily schedules in their pre-sleep questionnaires. 
Subject

Methods
Tw enty subjects, 10 men and 10 women, between 22 and 54 years of age, Table 2 .
Stanford Sleepiness Scale were evaluated in a 2 week open label treatment study. Subj ects recei ved no treatm ent durin g the first week (baseline) follow ed by one week of treatment wearing the Breathe Right® nasal dilator devic e while they slept. The Stanford Sleepiness Scale,' pre-a nd post-sleep questionnaires, and bed partner post-sleep que stionnaires were used to assess the subject's status durin g baseline as well as durin g the treatment period. A description of the Stanford Sleepiness Scale is listed in Tabl e I. Prio r to enrollment into the study, a telephone scree n was obtained that eliminated subjec ts who suffered from diagnosed obstructive sleep apnea. Males or females were eligible. The age range for enrollment eligibility was 21 to 55 years old ( Table 2 Demographi c Data). Subjects without a bed partner were excluded. Subje cts were required to have a subjec tive history of snoring of three month s or longer.
Written informed con sent was obtained. Subjects were given instructions to abstain from all alcohol consumption dur ing the study and to avoid caffeine after 2:00 p.m. The subjec ts were instructed to take no drug s or compounds unless they were indicated. If the subjec t developed a co ld, influenza, or other illness during the cour se of the study, they were asked to consult with study personnel prior to takin g any medication . Subj ects were asked not to compare questionnaire answers with previou s entries or to d iscuss current entri es with their bed partners. Subjects were asked not to nap if they normally did not do so and were asked to maintain a Instructions for applying the nasal dilator with a Table 3 . diagram detailing application were provided. The nose was wiped with tis-Subjective sue or palm of the hand to : . . . . P~a: ; r a~m~e~t . : : : : er~=~~=-_=:.:::..:-f-=~_~=~_ remove 'excess oil. The backing of the adhesive was then removed and the Breathe Right® nasal di-l ator was then centered over the bridge ofthe nose and the ends folded down such that the lower plastic strip was located over the nasal crease. ()nly the tabs (if any) extended beyond the nose onto the face, otherwise a smaller size was used ( Table 2 ). Subjects were asked to prepare for 'pc .05; 2p< .0 I ; 3bedpartner rating. bed and place the device on just before lights out. The Stanford Sleepiness Scale was completed before every meal and the pre-sleep questionnaire was completed after getting ready for bed but before lights out. The bed partner completed their questionnaire upon awakening but after their first morning urine. Post-sleep questionnaires were completed within thirty minutes after awakening. binomial probability: 'pc .01; 2p< .05
DIscussIon
The results of this study shows Breathe Right® nasal dilator subjectively improves snoring loudness in 75% of
Results
The mean and standard deviation for each parameter are listed in Table 3 . Improvements were noted in most parameters. The significance of the improvement compared to baseline was tested using a paired t test and corrected for multiple contrasts using the Bonferroni method. A significant decrease (p<.O I) in daytime sleepiness as measured by the Stanford Sleepiness Scale was demonstrated ( Figure 2 ). Next morning assessment of ease of breathing improved significantly from baseline (p<.05).
Subjective changes from baseline were evaluated using a binomial probability sign test (Table 4 ). A significant number ofsubjects showed improvement in each of the three sleepiness assessments throughout the day. The number of subjects reporting improvement for ease of breathing, morning sleepiness, quality of sleep, morning concentration, and number of awakenings were also significant. A significant proportion of bed partners reported improvements as well for snoring loudness and movement ( Figure 3 ). . Additional comments made by the participants generally reflected a high degree of satisfaction with the device . However, six of the subjects indicated difficulty with the appliance spontaneously lifting offat the ends by morning at least once during active treatment. ...
Acti 'ely d est roys
Il-lactamaseI .IP I' I Up U. lh' l lII l l.I l ll w"I,III) \\ 110'11 \ . ltl 'U "l'n IU I.kl.lIll.t "'· l ' l h l l l . l l l' 'I l!.1I1111l .. II.,C, lUll" : I . Nn l l U ', \\ 11~' 11 .\ 1'1', ( ; l l l U d l l l~UN fort .? T he nose acco unts fo r ap pro xim ately half of the total airway res istance to airfl ow and nasal o bstruc tion can cause an increased snoring and slee p apnea freq uency and se verity." Dur ing norm al slee p the tone of the phar yngea l mu scul ature is dec reased with a resulta nt increa se in resistan ce to airl1ow. Insp iratory pressure, which mu st increase to co unter the e ffect , can be stro ng eno ugh to co ntrib ute to an ai rway obstruction by the non -rigid part s of the a irway , i.e., the pharyn x, ve lopharynx and hypopharynx. By d ilating nasa l a irways, a decrea se in nasal air wa y resistance occ urs which may result in less sno ring and slee p fragm entation. Ideall y, rhinoscopy and nasal resistance sho uld have been perform ed to determin e tho se patient s wh o would most likel y benefi t from ex ternal nasal d ilation. However , the intent of th is study was to assess efficacy among a sample of those who had "s noring for 3 mon ths." Having estab lished a clear indi cation for e fficac y, fur ther stud ies sho uld cons ide r more stringe nt incl usion criteria and objective ly quantify snoring cha nges and e ffec ts on di sordere d breathing usin g polysom nograph ic techni qu es. 
